The Scotts Miracle-Gro Company filings document the formal record for a North American branded consumer lawn and garden company. Recent 8-K disclosures furnish operating results and financial condition, revised historical financial information reflecting Hawthorne as a discontinued operation, and the completed sale of The Hawthorne Gardening Company.
The filing record also covers capital structure and governance matters, including a senior secured credit agreement, shareholder approval of an amended and restated Long-Term Incentive Plan, forms of restricted stock unit, performance unit and stock option awards, and definitive proxy disclosures on annual meeting proposals and executive compensation.
Roberto Candelino, a director of The Scotts Miracle-Gro Company (SMG), reported a small acquisition of company shares. On 09/05/2025 he received 36 common shares as dividend equivalent rights related to DSU/RSU grants at an economic value of $63.04 per share. The filing shows he beneficially owned 108 common shares following the transaction, held directly.
The Form 4 was signed on behalf of Mr. Candelino by an attorney-in-fact on 09/09/2025. The filing explains that dividend equivalent rights track DSU/RSU vesting and are each economically equivalent to one common share.
James Hagedorn, Chairman & CEO of The Scotts Miracle-Gro Company (SMG), reported acquiring 2,297.999 units of phantom stock on 09/05/2025. Each phantom share represents the right to one common share or its cash value. The reported acquisition was at a per-unit reference price of $63.341 and increases Hagedorn's beneficial ownership to 224,273.963 common shares. The phantom shares are payable in cash following termination of employment, and the reporting person may transfer the phantom stock into an alternative investment at any time. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Hagedorn on 09/09/2025.
Edith Aviles, a director of The Scotts Miracle-Gro Company (SMG), reported a Section 16 transaction dated 09/05/2025. The filing shows the acquisition of 104 dividend equivalent rights that are the economic equivalents of common shares, recorded at $63.04 per share. After the reported transaction, Ms. Aviles directly beneficially owned 662 common shares. The filing was signed on behalf of Ms. Aviles by an attorney-in-fact on 09/09/2025 and explains that dividend equivalent rights vest proportionately with the related DSUs/RSUs.
Mark D. Kingdon, a director of The Scotts Miracle-Gro Company (SMG), reported an acquisition of 91 dividend equivalent rights tied to DSU/RSU awards on 09/05/2025. The filing shows each dividend equivalent right is economically equivalent to one common share and the transaction price reported is $63.04 per share. After this reported acquisition, Mr. Kingdon beneficially owns 506 common shares in a direct ownership form. The Form 4 was submitted with a signature by an attorney-in-fact on behalf of the reporting person on 09/09/2025.
Insider transaction summary: Peter E. Shumlin, a director of The Scotts Miracle-Gro Company (SMG), reported the acquisition of 159 dividend-equivalent rights related to DSU/RSU grants on 09/05/2025. The reported price per share equivalent is $63.04 and, after the transaction, Mr. Shumlin beneficially owns 1,023 common shares on a direct basis.
Transaction detail: The filing explains that dividend equivalent rights accrue on DSU/RSU grants and become exercisable proportionately with the underlying units; each right is economically equivalent to one common share. The Form 4 was signed by an attorney-in-fact on 09/09/2025.
Adam Hanft, a director of The Scotts Miracle-Gro Company (SMG), reported a Form 4 disclosing a transaction dated 09/05/2025. The filing shows the acquisition of 104 dividend equivalent rights related to DSU/RSU grants, with an indicated price of $63.04 and resulting beneficial ownership of 662 common shares in a direct form. The filer notes dividend equivalent rights accrue on DSUs/RSUs and become exercisable proportionately, each equivalent equaling one common share. The Form 4 was signed by an attorney-in-fact on behalf of Mr. Hanft on 09/09/2025. The filing does not provide further context on total holdings outside the reported 662 shares.
Mark J. Scheiwer, Executive Vice President, Chief Financial Officer and Chief Accounting Officer of The Scotts Miracle-Gro Company (SMG), reported acquisitions on 09/05/2025. The filing discloses the acquisition of 10.994 units of phantom stock (each unit representing the right to one common share or cash value) and 43 dividend equivalent rights, each tied to common shares. The phantom stock is payable in cash following termination of employment and may be transferred into an alternative investment at any time. The report was signed by an attorney-in-fact on 09/09/2025.
Brian E. Sandoval, a director of The Scotts Miracle-Gro Company (SMG), acquired 156 dividend equivalent rights tied to DSU/RSU awards on 09/05/2025 at an attributable price of $63.04 per share. After the transaction, Mr. Sandoval beneficially owned 965 common shares directly. The filing explains that each dividend equivalent right represents the economic equivalent of one common share and vests proportionately with the related DSUs/RSUs. The Form 4 was signed by an attorney-in-fact on 09/09/2025 and discloses the director-level insider acquisition without additional amendments or other transaction types.
Stephen L. Johnson, a director of The Scotts Miracle-Gro Company (SMG), reported an acquisition on 09/05/2025 of 133 dividend equivalent rights tied to DSU/RSU grants at an economic price of $63.04 each. The filing states each dividend equivalent right is the economic equivalent of one common share. Following the reported transaction, Mr. Johnson beneficially owned 789 common shares directly. The Form 4 was signed on behalf of Mr. Johnson by an attorney-in-fact on 09/09/2025.
David C. Evans, a director of The Scotts Miracle-Gro Company (SMG), acquired dividend equivalent rights equal to 104 common shares on 09/05/2025. These rights are the economic equivalent of one common share each and vest/exercise proportionately with the related DSUs/RSUs. The reported acquisition was recorded at a per-share economic price of $63.04 and after the transaction Mr. Evans directly beneficially owned 662 common shares. The Form 4 was submitted by an attorney-in-fact on behalf of Mr. Evans.